Ghana is preparing for a possible outbreak after the infectious and deadly Marburg virus was detected in the country for the first time, according to the United Nation’s news release.
www.thegatewaypundit.com
I'm pretty sure Marbug has a mRNA vaccine by Pfizer already...
Phase 1 trial begins for Marburg virus vaccine
The Walter Reed Army Institute of Research, or WRAIR, began a phase 1 clinical trial to evaluate the safety and tolerability of two different doses of a Marburg vaccine candidate in humans and determine if the vaccine generates enough antibodies and T-cell responses to the Marburg virus.
The vaccine candidate, VRC-MARADC087-00-VP, was developed by the National Institute of Allergy and Infectious Diseases’ Vaccine Research Center.
“In today’s global environment of mass migration and rapid international travel, infectious diseases can spread with astonishing speed and impact. Development of an effective vaccine against Marburg virus is a critical public health and global health security need” Lt. Col. Melinda Hamer, MD,MPH, chief of WRAIR Clinical Trials Center in Silver Springs, Maryland, told
Infectious Disease News.
According to a news release, study of the recombinant chimpanzee adenovirus type-3 vectored Marburg virus vaccine will include splitting 40 healthy adult volunteers into two groups to test two different doses of the vaccine.
Volunteers will be monitored for 1 year for signs of immune system response to determine the durability of those responses and the safety of each dosage. Additional objectives of the study are to evaluate vaccine-induced mRNA expression and to isolate monoclonal antibodies to the Marburg virus, which may prove useful in the prevention or treatment of Marburg, Hamer said.
From Wikipedia (what "outbreaks" aka plandemics to expect next):
The first human clinical trials using an mRNA vaccine against an infectious agent (
rabies) began in 2013.
[37][38] Over the next few years, clinical trials of mRNA vaccines for a number of other viruses were started. mRNA vaccines for human use have been studied for infectious agents such as
influenza,
[39] Zika virus,
cytomegalovirus, and
Chikungunya virus.
[40][41]
In March 2022
Moderna announced the development of mRNA vaccines for 15 diseases:
Chikungunya virus,
COVID-19,
Crimean-Congo haemorrhagic fever,
Dengue,
Ebola virus disease,
HIV,
Malaria,
Marburg virus disease,
Lassa fever,
Middle East respiratory syndrome coronavirus (MERS-CoV),
Nipah and
henipaviral diseases,
Rift Valley fever,
Severe fever with Thrombocytopenia syndrome,
Tuberculosis and
Zika.
[42][43]
www.breitbart.com
theconservativetreehouse.com
www.foxnews.com
